Lupin partners with Celnova Pharma to distribute NaMuscla in Argentina and Colombia
NaMuscla (mexiletine) to be commercialised for the treatment of non-dystrophic myotonic disorders in adults
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
distribution agreement
Sanofi signs distribution pact with Cipla for CNS portfolio in India
Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium
Sanofi India, Emcure Pharma announce exclusive distribution partnership
Emcure to distribute and promote Sanofi’s cardiovascular brands in India
AstraZeneca India, Mankind Pharma sign pact to distribute asthma medicine in India
AstraZeneca will retain the intellectual property rights to budesonide and formoterol fumarate dihydrate and will continue to be…
DKSH signs distribution pact with Lactalis in Asia and Europe
Lactalis provides high-purity pharma lactose to formulate oral solid dose medicines, conforming with the lactose monohydrate…
Generic Pharmasec signs distribution and marketing pact with Abbott Point of Care
Aim to increase i-STAT devices penetration by at least 1,000 additional hospital set-ups in the next 24 months by creating…
Caplin Steriles signs distribution agreement with Xellia Pharmaceuticals
The former to license five of its injectable ANDAs to Xellia Pharmaceuticals for commercialisation in the US
DKSH to commercialise seven generic formulations of Biocon Pharma in Singapore and Thailand
The formulations belong to various therapeutic areas like diabetology, cardiology, oncology and immunology
Lupin signs distribution agreement in EU territories for orphan drug NaMuscla
Reportedly, NaMuscula is the first and only licensed product for myotonia in adults with non-dystrophic myotonic disorders
Cipla in distribution agreement with SII for paediatric vaccines in Europe
The collaboration enables Cipla to enter into the vaccines segment